Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1709

  • Showing results for milan plus. Your search for Milan Pleus retrieved no results.
1.

Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study.

Pan T, Mu LW, Wu C, Wu XQ, Xie QK, Li XS, Lyu N, Li SL, Deng HJ, Jiang ZB, Lin AH, Zhao M.

J Cancer. 2017 Sep 29;8(17):3506-3513. doi: 10.7150/jca.19964. eCollection 2017.

2.

Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial.

Zamboni P, Tesio L, Galimberti S, Massacesi L, Salvi F, D'Alessandro R, Cenni P, Galeotti R, Papini D, D'Amico R, Simi S, Valsecchi MG, Filippini G; Brave Dreams Research Group.

JAMA Neurol. 2017 Nov 18. doi: 10.1001/jamaneurol.2017.3825. [Epub ahead of print]

3.

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.

Gianotti N, Poli A, Nozza S, Galli L, Galizzi N, Ripa M, Merli M, Carbone A, Spagnuolo V, Lazzarin A, Castagna A.

BMC Infect Dis. 2017 Nov 16;17(1):723. doi: 10.1186/s12879-017-2831-9.

4.

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.

Boeri L, Capogrosso P, Ventimiglia E, Cazzaniga W, Pederzoli F, Moretti D, Dehò F, Montanari E, Montorsi F, Salonia A.

Sci Rep. 2017 Nov 9;7(1):15179. doi: 10.1038/s41598-017-15435-0.

5.

Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.

Pretegiani E, Rosini F, Rufa A, Gallus GN, Cardaioli E, Da Pozzo P, Bianchi S, Serchi V, Collura M, Franceschini R, Bianchi Marzoli S, Dotti MT, Federico A.

J Neurol Sci. 2017 Nov 15;382:29-35. doi: 10.1016/j.jns.2017.09.018. Epub 2017 Sep 14.

PMID:
29111013
6.

Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.

Meazza C, Cefalo G, Massimino M, Daolio P, Pastorino U, Scanagatta P, Morosi C, Podda M, Ferrari A, Terenziani M, Spreafico F, Casanova M, Parafioriti A, Collini P, Gandola L, Bastoni S, Biassoni V, Schiavello E, Chiaravalli S, Puma N, Bergamaschi L, Luksch R.

Med Oncol. 2017 Nov 1;34(12):191. doi: 10.1007/s12032-017-1052-9.

PMID:
29094224
7.

STAR syndrome plus: The first description of a female patient with the lethal form.

Bedeschi MF, Giangiobbe S, Paganini L, Tabano S, Silipigni R, Colombo L, Crippa BL, Lalatta F, Guerneri S, Miozzo M.

Am J Med Genet A. 2017 Dec;173(12):3226-3230. doi: 10.1002/ajmg.a.38484. Epub 2017 Oct 31.

PMID:
29088509
8.

Does cryopreservation influence perinatal outcome after blastocyst-stage vs cleavage-stage transfer? A systematic review and meta-analysis.

Alviggi C, Conforti A, Carbone IF, Borrelli R, De Placido G, Guerriero S.

Ultrasound Obstet Gynecol. 2017 Oct 27. doi: 10.1002/uog.18942. [Epub ahead of print] Review.

PMID:
29077229
9.

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer.

Wainberg ZA, Alsina M, Soares HP, Braña I, Britten CD, Del Conte G, Ezeh P, Houk B, Kern KA, Leong S, Pathan N, Pierce KJ, Siu LL, Vermette J, Tabernero J.

Target Oncol. 2017 Oct 24. doi: 10.1007/s11523-017-0530-5. [Epub ahead of print]

PMID:
29067643
10.

Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model.

Tessaro I, Modina S, Lodde V, Sivelli G, Franciosi F, Terzaghi L, Luchini P, Rumio C, Luciano AM.

J Reprod Infertil. 2017 Jul-Sep;18(3):288-297.

11.

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).

Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

PMID:
29054815
12.

Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.

Nozza A, Terenghi F, Gallia F, Adami F, Briani C, Merlini G, Giordano L, Santoro A, Nobile-Orazio E.

Br J Haematol. 2017 Oct 19. doi: 10.1111/bjh.14966. [Epub ahead of print]

PMID:
29048107
13.
14.

Effects of regional perfusion block in healthy and injured lungs.

Cambiaghi B, Vasques F, Mörer O, Ritter C, Mauri T, Kunze-Szikszay N, Holke K, Collino F, Maiolo G, Rapetti F, Schulze-Kalthoff E, Tonetti T, Hahn G, Quintel M, Gattinoni L.

Intensive Care Med Exp. 2017 Oct 13;5(1):46. doi: 10.1186/s40635-017-0161-2.

15.

Policy, politics and public health.

Greer SL, Bekker M, de Leeuw E, Wismar M, Helderman JK, Ribeiro S, Stuckler D.

Eur J Public Health. 2017 Oct 1;27(suppl_4):40-43. doi: 10.1093/eurpub/ckx152.

PMID:
29028231
16.

When nonplatinum is the answer: the role of trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer.

Colombo N.

Future Oncol. 2017 Oct;13(23s):23-29. doi: 10.2217/fon-2017-0319. Epub 2017 Oct 11.

PMID:
29020821
17.

Socioeconomic deprivation worsens the outcomes of Italian women with hormone receptor-positive breast cancer and decreases the possibility of receiving standard care.

Di Salvo F, Caranci N, Spadea T, Zengarini N, Minicozzi P, Amash H, Fusco M, Stracci F, Falcini F, Cirilli C, Candela G, Cusimano R, Tumino R, Sant M; Socioeconomic Inequalities and Oncological Outcomes Italian Working Group.

Oncotarget. 2017 Jul 22;8(40):68402-68414. doi: 10.18632/oncotarget.19447. eCollection 2017 Sep 15.

18.

Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma.

Balza E, Castellani P, Moreno PS, Piccioli P, Medraño-Fernandez I, Semino C, Rubartelli A.

Oncotarget. 2017 Jun 27;8(40):67482-67496. doi: 10.18632/oncotarget.18713. eCollection 2017 Sep 15.

19.

Effect of superoxide dismutase supplementation on sperm DNA fragmentation.

Negri L, Benaglia R, Monti E, Morenghi E, Pizzocaro A, Levi Setti PE.

Arch Ital Urol Androl. 2017 Oct 3;89(3):212-218. doi: 10.4081/aiua.2017.3.212.

20.

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.

Capetti AF, Cossu MV, Orofino G, Sterrantino G, Cenderello G, De Socio GV, Cattelan AM, Soria A, Rusconi S, Riccardi N, Baldin GM, Niero FP, Barbarini G, Rizzardini G.

BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

Supplemental Content

Loading ...
Support Center